Funding for this research was provided by:
The Research Foundation–Flanders (G0F7716N, G0C9320N, G0B4420N, 1158318N)
KU Leuven (StG/15/021BF)
European Union’s Horizon 2020 (12T1217N)
The Research Foundation–Flanders (1S72719N)
Received: 3 May 2021
Accepted: 13 October 2021
First Online: 1 November 2021
: Animal work carried out in this study was covered by a project license (ECD_P003-2016) approved by the KU Leuven Animal Ethics Committee to Vincent Pasque.
: Not applicable.
: V.P. is an adviser and consultant for LifeTech Venture Capitals.